Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02332096 · ClinicalTrials.gov registry record

Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation

A clinical trial of Atrial Fibrillation and Obstructive Sleep Apnea, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
130
Enrollment target
1
Study location

NCT02332096 is a study of Atrial Fibrillation and Obstructive Sleep Apnea that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 130 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02332096, a study of Atrial Fibrillation and Obstructive Sleep Apnea, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
130 participants
Enrollment target
1
Study location

Study Summary

Diagnosis and treatment of sleep apnea with continuous positive airway pressure (CPAP) therapy has been shown to decrease arrhythmia recurrence in patients with AF following ablation. However, patients with AF undergoing ablation are not routinely screened for sleep apnea, despite an estimated sleep apnea prevalence of 25% in the general population, and perhaps higher among patients with AF. Home sleep testing is frequently used for evaluation of sleep apnea.

Interventions

  • DEVICE Home Sleep Testing Device

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2015-06
Est. Completion 2020-02-07

What the Registry Record Tells You About NCT02332096

The ClinicalTrials.gov registry entry for NCT02332096 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (96% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Home Sleep Testing Device is the first listed.

NCT02332096 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02332096 about?

NCT02332096 is a clinical study titled "Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation". Diagnosis and treatment of sleep apnea with continuous positive airway pressure (CPAP) therapy has been shown to decrease arrhythmia recurrence in patients with AF following ablation. However, patients with AF undergoing ablation are not routinely screened for sleep apnea, despite an estimated sleep...

What is the current status of trial NCT02332096?

This trial is currently completed. The enrollment target is 130 participants. The study started on 2015-06. Estimated completion is 2020-02-07.

What conditions does trial NCT02332096 study?

This clinical trial studies the following conditions: Atrial Fibrillation, Obstructive Sleep Apnea, Cardiac Arrhythmias.

What interventions are being tested in trial NCT02332096?

The interventions under investigation include: Home Sleep Testing Device (DEVICE).

Who is sponsoring clinical trial NCT02332096?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02332096 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.